216 related articles for article (PubMed ID: 37537642)
1. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanisms of autoinhibition and substrate recognition by the ubiquitin ligase HACE1.
Düring J; Wolter M; Toplak JJ; Torres C; Dybkov O; Fokkens TJ; Bohnsack KE; Urlaub H; Steinchen W; Dienemann C; Lorenz S
Nat Struct Mol Biol; 2024 Feb; 31(2):364-377. PubMed ID: 38332367
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
[TBL] [Abstract][Full Text] [Related]
4. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E
Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937
[TBL] [Abstract][Full Text] [Related]
5. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
[TBL] [Abstract][Full Text] [Related]
6. A structural element within the HUWE1 HECT domain modulates self-ubiquitination and substrate ubiquitination activities.
Pandya RK; Partridge JR; Love KR; Schwartz TU; Ploegh HL
J Biol Chem; 2010 Feb; 285(8):5664-73. PubMed ID: 20007713
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities
Singh S; Ng J; Nayak D; Sivaraman J
J Biol Chem; 2019 Dec; 294(52):19934-19949. PubMed ID: 31732561
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
[TBL] [Abstract][Full Text] [Related]
9. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
[TBL] [Abstract][Full Text] [Related]
10. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-independent proteasomal degradation of Spindlin-1 by the E3 ligase HACE1 contributes to cell-cell adhesion.
Palicharla VR; Gupta D; Bhattacharya D; Maddika S
FEBS Lett; 2021 Feb; 595(4):491-506. PubMed ID: 33421097
[TBL] [Abstract][Full Text] [Related]
12. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
[TBL] [Abstract][Full Text] [Related]
13. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models.
Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D
Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of HECT domain of UBE3C E3 ligase and its ubiquitination activity.
Singh S; Sivaraman J
Biochem J; 2020 Mar; 477(5):905-923. PubMed ID: 32039437
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.
Sun A; Tian X; Chen Y; Yang W; Lin Q
Pathol Oncol Res; 2023; 29():1610931. PubMed ID: 36825281
[TBL] [Abstract][Full Text] [Related]
16. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity.
Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B
J Virol; 2019 May; 93(9):. PubMed ID: 30787155
[TBL] [Abstract][Full Text] [Related]
17. Emerging role and mechanism of HACE1 in the pathogenesis of neurodegenerative diseases: A promising target.
Zang C; Liu H; Ning J; Chen Q; Jiang Y; Shang M; Yang Y; Ma J; Dong Y; Wang J; Li F; Bao X; Zhang D
Biomed Pharmacother; 2024 Mar; 172():116204. PubMed ID: 38364733
[TBL] [Abstract][Full Text] [Related]
18. Redefining the catalytic HECT domain boundaries for the HECT E3 ubiquitin ligase family.
Kane EI; Beasley SA; Schafer JM; Bohl JE; Lee YS; Rich KJ; Bosia EF; Spratt DE
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36111624
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of esophageal cancer progression through HACE1-TRIP12 interaction and associated RAC1 ubiquitination and degradation.
Hu Y; Zhu Z; Xu Y; Zaman MF; Ge Y; Hu J; Tang X
J Cancer; 2024; 15(10):3114-3127. PubMed ID: 38706891
[No Abstract] [Full Text] [Related]
20. Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5.
Hodáková Z; Grishkovskaya I; Brunner HL; Bolhuis DL; Belačić K; Schleiffer A; Kotisch H; Brown NG; Haselbach D
EMBO J; 2023 Aug; 42(16):e113348. PubMed ID: 37409633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
